Journals / MN Oftalmoloji / 2005 / Cilt: 12 - Sayı: 2

Toxic effect of preservative material in ophthalmic solutions on tear functions and ocular surface

Oftalmik solüsyonlardaki prezervan maddelerin gözyaşı fonksiyonları ve oküler yüzeydeki toksik etkisi

Pages
146–151
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

All these changes reverse to normal after switching to preservative free drop

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To investigate the toxic effect of benzalkonium chloride, a preservative that is commonly used in ophthalmic solutions, on ocular surface and on tear film functions and also reversibility of this effect.
📊
Key Findings & Data:Material and Method: Tshirtyeight eyes of 19 patients using timolol maleat (0.5%) because of primary open angle glaucoma (POAG) or ocular hipertension were included in the study.
💡
Conclusion & Impact:All these changes reverse to normal after switching to preservative free drop
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Koruyucular · farmasötik · Benzalkonyum bileşikleri

Abstract

Purpose: To investigate the toxic effect of benzalkonium chloride, a preservative that is commonly used in ophthalmic solutions, on ocular surface and on tear film functions and also reversibility of this effect. Material and Method: Tshirtyeight eyes of 19 patients using timolol maleat (0.5%) because of primary open angle glaucoma (POAG) or ocular hipertension were included in the study. The changes in the tear film functions and the ocular surface were evaluated by Schirmer I test, fluorescein break up time (BUT), rose bengal stainning and impression cytology. Then the medication was switched to preservative free timolol maleat and all tests were repeated at 1st and 2nd months. In addition intraocular pressures were measured at each follow up. Results: The mean of Schirmer I tests while using timolol maleat with preservative was 7.05 mm/5 min. It increased to 9.8 mm/5 min when patients were switched to preservative free drop (p<0.002). At the beginning the fluorescein BUT was 8.29 sec and was increased to 13.18 sec while using preservative free drop (p<0.01). While 19% of the eyes were stainned with rose bengal when the patients were using preservative containing eye drop, it decreased to the level of 5% at the 2nd month of preservative free drop usage (p=0.001). Impression cytology evaluation showed that 50% of the eyes were at stage 0 while using timolol maleat with preservative. It increased to 76.3% after 2 months of preservative free drop usage (p=0.02). There was no significant difference between the effectiveness of medications with and without preservative (p>0.05). Conclusion: Chronic exposure to benzalkonium chloride results in worsenning of tear film function tests increase in biological stainning of ocular surface, squamous metaplasia in conjunctiva and loss of goblet cells. All these changes reverse to normal after switching to preservative free drop

Özet

Amaç: Oftalmik solüsyonlarda sıklıkla kullanılan bir prezervatif olan benzalkonyum klorürün oküler yüzey ve gözyaşi filmi fonksiyonları üzerindeki toksik etkisini ve bu etkinin geri dönüşebilirliğini incelemek. Gereç ve Yöntem: Çalışmaya primer açık açılı glokom (PAAG) veya oküler hipertansiyon (OHT) nedeniyle timolol maleat (%0.5) kullanan 19 hastanın 38 gözü çalışmaya alındı. Gözyaşı filmi fonksiyonları ve oküler yüzey değişiklikler Schirmer I testi, floresein kırılma zamanı (FKZ), rose bengal ile boyanma, impresyon sitolojisi ile değerlendirildi. Daha sonra medikasyon prezervansız timolol maleat ile değiştirildi ve bütün testler 1. ve 2. aylarda tekrarlandı. Ayrıca her takipte hastaların göziçi basıncı (GIB) ölçüldü. Bulgular: Prezervanlı timolol maleat kullanırken Schirmer I testi ortalamas 7.05 mm/5dak idi (p 0.05). Sonuç: Kronik benzalkonyum klorür maruziyeti gözyaşı filmi fonksiyon testlerinde bozulma, oküler yüzey biyolojik boyanmasında artış, konjonktivada skuamoz metaplazi ve goblet hücre kaybı ile sonuçlanmaktadır. Bütün bu değişiklikler prezevansız damlaya geçildikten sonra normale dönmeye başlamaktadır.

🔖

Cite This Article

EVSEN, D. S., EVREN, Ö., HAN, Ö., GÜRSEL, E. (2005). Toxic effect of preservative material in ophthalmic solutions on tear functions and ocular surface. MN Oftalmoloji, Cilt: 12 - Sayı: 2, 146–151. https://ajindex.com/articles/296895

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kanski JJ. Clinical Ophthalmology, Edinburg: Butterworth Heinemann 2003:62-94.
  2. Broadway D, Grierson I, Hitchings R. Adverse Effects of Topical Antiglaucomatous Medications on Conjunctiva: Br J OphthalmoJ İ993; 77:590-6.
  3. Phillip P, Ellis MD. Ocular Therapeutics and Pharmacology: Preservatives-Antiseptics St Louis: Mosby 1981:278-9.
  4. Davies O'Conner PH, Hopkins GA, Pearson RM. The Action and Uses of Ophthalmic Drugs. London: Butterworth, 1989:63-73. Takahashi N. A New Method of Evaluating Quantitqtive time dependeny, Cytotoxicity of Ophthalmic Solutions in Cell Culture. Beta Adrenergic Blocking Agents: Graefe's Arch Clin Exp Ophtalmol 1983; 220:264-7.
  5. Baudoin G, Pisella PJ, Fillacier K, et al. Ocular Surface Inflamatory Changes Induced by Topical Antiglaucoma Drugs Ophthalmology 1999; 106:556-63.
  6. Pisella P, Fillacier K, Elena P, Debbash C, Baudoin C. Comparison of Effects Of Preseved and Unpreseved Formulations of Timolol on the Ocular Surface/of Albino Rabbits. Ophthalmic Res 2003; 2:3-8. Burstein NL. The Effects of Topical Drugs and Preservatives on the Tears and Corneal Epithelium in Dry Eye. Trans Ophthalmol Soc UK 1985; 104:402-9.
  7. Teping C, Wiedemann B. The COMOD System: A Presevative-free Multidose Containers for Eye Drops. Klin Monatsbl Augenheilkd 1994; 205: 210-7.
  8. Egbert RP, Lauber S, Maurie MD. A Simple Conjunctival Biopsy. Am J Ophthalmol 1977; 84:798-801.
  9. Nelson JD, Havaner RV, Cameron D. Cellulose Acetat Impressions of the Ocular Surface. Arch Ophthalmol 1983; 101:1869-72. Van Bijsterveld OP.: Diagnostic Tests in Sicca Syndromes. Arch Ophthalmol 1969; 82:10-4. Steuhl KP. Ultrastructure of Cojunctiva Epthelium. Dev Ophthalmol 1989; 19:1-104.
  10. Turaçlı E, Budak K, Kaur A, Mızrak B, Cemil E. The Effects of Long-term Topical Glaucoma Medications on Conjunctival Impression Cytology. Int Ophthalmol 1997; 21:27-33.
  11. Özdemir M, Büyükbeşe MA, Çetinkaya A, Özdemir G. Risk Factors of Ocular Surface Disorders in Patients With Diabetes Mellitus. Diabetes Res Clin Practice 2003; 59:195-9.
  12. Scheffer C, Tseng G. Staging of Conjunctival Squamous Metaplasia by Impression Cytqlogy. Ophthalmology 1985; 92:728-33.
  13. Yalvaç, Sağdıç I, Gedikoğlu G, Karagöz Y, et al. Effects of Antiglaucoma Drugs on Ocular Surface. Acta Ophthalmol Scand 1995; 73:246-8.
  14. De Saint Jean M, Debbash J, Brignole F, Rat P, Warnet JM, Baudoin C. Toxicity of Preseved and Unpreserved Antiglaucoma Topical Drugs in an Invitro Model of Conjunctival Cells. Curr Eye Res 1984; 20:85-94.
  15. Nuzzi R, Finazzo C, Ce